多途径联合方案:多次小剂量静脉联合关节周围注射地塞米松改善全膝关节置换术后早期结局
这项前瞻性双盲随机对照试验比较五种小剂量围手术期地塞米松方案对全膝关节置换术后早期恢复的影响。联合组(术前术后静脉加术中关节周围注射)在术后72小时内镇痛、降低恶心呕吐和促进早期活动度方面平衡了疗效与安全性。
要点
- 联合多途径地塞米松方案在术后72小时内镇痛效果优于单纯静脉或单纯关节周围注射。
- 静脉地塞米松组恶心呕吐发生率低于对照组和单纯关节周围注射组。
- 所有干预组术后1至3天活动度均高于对照组。
核心结论
- 在初次全膝关节置换术中,小剂量地塞米松可减轻术后72小时内的疼痛和恶心呕吐并促进早期活动度恢复。
- 多途径联合方案平衡了疗效与安全性,支持优化和个体化的地塞米松路径。
研究设计与样本
- 前瞻性、双盲、随机对照试验,患者随机分为五组。
- 联合组接受术前和术后静脉剂量加术中关节周围注射的联合方案。
- IV2组接受术前和术后静脉剂量,IV1组接受单次术前静脉剂量。
- PAI组接受术中关节周围注射,CON组不接受地塞米松。
主要发现
- 与CON组相比,联合组术后第1至3天静息痛更低,PAI组术后第1至2天疼痛更低。
- 联合组和PAI组术后第1至2天被动屈曲痛更低,术后第3天行走痛更低。
- 与IV2和IV1组相比,联合组在相同时间窗内静息、被动屈曲和行走痛均更低。
- 联合组、IV2组和IV1组恶心呕吐发生率低于CON组和PAI组,PAI组与CON组无差异。
- 术后第1至3天所有干预组活动度均高于CON组。
关键数值与推荐
- 联合组、IV2组和IV1组C反应蛋白和白细胞介素-6均低于CON组。
- 联合组和PAI组外周白细胞计数和中性粒细胞百分比升高。
- 联合组发生1例轻度胃肠道出血,未观察到其他严重不良事件。
临床怎么用
- 全膝关节置换围手术期可考虑小剂量地塞米松多途径联合方案以改善早期镇痛和恢复。
- 需根据患者情况个体化选择地塞米松给药途径和剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of our study was to compare five low-dose perioperative dexamethasone (DEX) regimens on early recovery after total knee arthroplasty and identify an optimal route combination. METHODS: In a prospective, double-blind, randomized controlled trial, patients were randomized to five groups. The COMB (combination) group received a combined regimen of pre and postoperative intravenous (IV) doses with intraoperative periarticular injection (PAI), the IV2 group received pre and postoperative IV doses, the IV1 group received a single preoperative IV dose, the PAI group received intraoperative PAI, and the CON (control) group received no DEX. Outcomes within 72 hours were visual analog scale pain (rest, passive flexion, and ambulation); postoperative nausea and vomiting (PONV); opioid consumption; range of motion (ROM); C-reactive protein; interleukin-6; white blood cell count and neutrophil percentage; Knee Society Score; knee swelling; Quality of Recovery-15; lengths of stay; and complications. RESULTS: Versus the CON group, the COMB group showed lower rest pain on postoperative days (PODs) 1 to 3, and the PAI group showed lower pain on POD one to two. Both groups had lower passive flexion pain on POD one to two and lower ambulation pain on POD three. Compared with IV2 and IV1 groups, the COMB group yielded lower rest, passive-flexion, and ambulation pain across the same windows. The PONV rates were lower in the COMB, IV2, and IV1 groups than in CON and PAI groups; the PAI group did not differ from the CON group. Across POD one to three, ROM was higher in all intervention groups than in the CON group. Both C-reactive protein and interleukin-6 were lower in the COMB, IV2, and IV1 groups versus the CON group. Peripheral white blood cell count and neutrophil percentage increased in the COMB and PAI groups. There was one mild gastrointestinal bleed that occurred in the COMB group; no other serious adverse events were observed. CONCLUSIONS: In primary total knee arthroplasty, low-dose DEX reduced pain and PONV within 72 hours and facilitated early ROM recovery. A combined multiroute regimen balanced efficacy and safety, supporting optimized and individualized DEX pathways.
引用
- Xia Y, Song H, Jin J, et al. A Combined Multi-Route Regimen of Multiple Low-Dose Intravenous and Periarticular Dexamethasone Improves Perioperative Outcomes After Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Trial. J Arthroplasty. 2026. PMID: 41786257. doi:10.1016/j.arth.2026.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。